Human Genome Sciences, Inc. http://www.alacrastore.com/company-snapshot/Human_Genome_Sciences_Inc-1078438 Thursday, July 24, 2008 3:29:39 PM 1078438 Human Genome Sciences, Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0005-26893012newstex/PRN-0005-26893012xml ROCKVILLE, Md., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that David P. Southwell has been appointed to the HGS Board of Directors. He will also serve as...0700000007005000090000000901500004000000040020000400200604002001040160000401600813000000130010001300100213010000130100050701400007014004070140127/24/2008 8:07:37 AM1800000018007000PR Newswire USPRN-0005-26893012HUMAN GENOME SCIENCES INCSEPRACOR INCDAVID P SOUTHWELLThomas WatkinsHGSISEPRNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26875425newstex/PRN-0005-26875425xml ROCKVILLE, Md., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it will sponsor a conference call to discuss its financial results for the quarter ended June...070000000700500013000000130010001300100207014000070140040400000004016000040160180401604804002000040020017/23/2008 5:06:35 PM180000001800400018008000PR Newswire USPRN-0005-26875425HUMAN GENOME SCIENCES INCHGSINewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1827875ccbn/T1827875norm...Good day everyone, and welcome to today's Human Genome Sciences conference call. As a reminder, today's call is being recorded. At this time I would like to turn the call over to H. Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. ... 7/16/2008 5:11:14 PMHuman Genome Sciences54.0000Human Genome Sciences Conference Call to discuss oncology portfolioHGSI5:00PM ETTranscriptT1827875Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1827875ccbn/B1827875norm...HGSI reported steps to advance oncology portfolio which includes the re-acquisition of rights to its TRAIL receptor antibodies. Strategy to expand and advance oncology portfolio involves a series of actions and Phase III programs are on track for commercialization. www.streetevents.comContact Us ... 7/16/2008 5:10:57 PMHuman Genome Sciences54.0000Human Genome Sciences Conference Call to discuss oncology portfolioHGSI5:00PM ETBriefB1827875Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25112338newstex/PRN-0005-25112338xml ROCKVILLE, Md., May #, May #, #### (PR Newswire delivered by Newstex) -- ROCKVILLE, Md., May # /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that John L. LaMattina, Ph.D., who retired in late...07000000070050000900000009015000040000000400200004002006040020010401600004016008070140000701401207014004070140080700300007003001070010000700100413000000130010001300100213010000130100055/8/2008 8:07:27 AM180000001800700018020000PR Newswire USPRN-0005-25112338HUMAN GENOME SCIENCES INCPFIZER INCJOHN L LAMATTINAThomas NULL WatkinsHGSIPFENewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1837783ccbn/B1837783norm...Has three strong Phase III products and an emerging pipeline that creates opportunities for future growth. ... 5/5/2008 7:11:00 PMHuman Genome Sciences54.0000EditedQ1 2008 Human Genome Sciences Earnings Conference Call SummaryHGSI5:00pm ETBriefB1837783Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1837783ccbn/T1837783norm...Welcome to the Human Genome Sciences first quarter #### financial results conference call. (OPERATOR INSTRUCTIONS) It's my pleasure to turn the call over to Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. Please go ahead. ... 5/5/2008 6:11:00 PMHuman Genome Sciences54.0000FinalQ1 2008 Human Genome Sciences Earnings Conference Call TranscriptHGSI5:00pm ETTranscriptT1837783Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25023642newstex/PRN-0005-25023642xml ROCKVILLE, Md., May #, May #, #### (PR Newswire delivered by Newstex) -- ROCKVILLE, Md., May # /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced financial results and key developments for the quarter...0700000007005000040000000400200004002006040020010401600004016018040160010700100007001004070140000701401207014008070140040701401907014009070030000700300113000000130010001300100213010000130100055/5/2008 5:06:49 PM1800000018020000180040001900000019001000PR Newswire USPRN-0005-25023642HUMAN GENOME SCIENCES INCThomas NULL WatkinsHGSINewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-24850822newstex/PRN-0005-24850822xml ROCKVILLE, Md., April ##, Apr. ##, #### (PR Newswire delivered by Newstex) -- ROCKVILLE, Md., April ## /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it will sponsor a conference call to discuss...070000000700500007014000070140041300000013001000130010020400000004016000040160180401604804002000040020014/28/2008 5:05:36 PM180000001800400018008000PR Newswire USPRN-0005-24850822HUMAN GENOME SCIENCES INCHGSINewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1770704ccbn/B1770704norm...Expects to have first Phase III data available by ####-end for Albuferon in treatment of chronic hepatitis C.... 2/25/2008 8:11:00 PMHuman Genome Sciences54.0000EditedQ4 2007 Human Genome Sciences Earnings Conference Call SummaryHGSI4:30pm ETBriefB1770704Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1770704ccbn/T1770704norm...Good morning, and welcome to the Human Genome Sciences fourth quarter and full year #### financial results conference call. Today's call is being recorded. At this time, I would like to turn the call over to H. Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. Please go ahead. ... 2/25/2008 6:11:00 PMHuman Genome Sciences54.0000FinalQ4 2007 Human Genome Sciences Earnings Conference Call TranscriptHGSI4:30pm ETTranscriptT1770704Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1748502ccbn/T1748502norm1/23/2008 4:14:11 PMHuman Genome Sciences106.0000FinalHuman Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)Conference Call TranscriptHGSI10:00am ET...Good morning and welcome to the Human Genome Sciences conference call. Today's call is being recorded. At this time, I will turn the call over to H. Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. ... TranscriptT1748502Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1748502ccbn/B1748502norm1/23/2008 1:12:11 PMHuman Genome Sciences106.0000EditedHuman Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)Conference Call SummaryHGSI10:00am ET...HGSI reported the modification of dosing in one arm of each of Phase # trials of Albuferon. In late ####, Co. expects to have first Phase # data for Albuferon. Expects to have all Phase # data for Albuferon by spring ####. ... BriefB1748502Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1733543ccbn/T1733543norm1/11/2008 5:11:00 PMHuman Genome Sciences54.0000FinalHuman Genome Sciences at JPMorgan Healthcare Conference TranscriptHGSI7:30am PT... - JPMorgan - AnalystGood morning everyone. Thank you for staying in there on the third day. My name is Richard Smith. I am -- I cover the small, MidCap biotech here at JPMorgan. It is my pleasure to introduce the next company, Human Genome Sciences. As many of you are probably aware, this Company is focused on protein therapeutics and antibodies, a number of products in late stage development, including LymphoStat-B and Albuferon. And with that, I will hand it over to the Company's President and CEO, Tom Watkins. ... TranscriptT1733543Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1696449ccbn/T1696449norm12/31/2007 6:05:36 PMHuman Genome Sciences54.0000FinalHuman Genome Sciences at 19th Annual Piper Jaffray Health Care Conference TranscriptHGSI10:00am ET... - Human Genome Sciences - President and CEO [Audio begins in progress] -- ### profile as we've tested in market research would give us majority market share in the marketplace, but there's further upside if we can demonstrate superior efficacy compared to Pegasys, and the #,### gives us that best chance. ... TranscriptT1696449Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1726893ccbn/B1726893norm12/31/2007 6:05:00 PMHuman Genome Sciences54.0000EditedHuman Genome Sciences Conference Call SummaryHGSI11:00am ET...HGSI reported Phase # trial of HGS-ETR# as first line therapy in combination with the chemotherapy agents paclitaxel and carboplatin in patients with non-small cell lung cancer. Expects to have data available by mid-#### from other Phase # trial of HGS-ETR# in combination with Velcade in patients with multiple myeloma. ... BriefB1726893Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1726893ccbn/T1726893norm12/31/2007 6:05:00 PMHuman Genome Sciences54.0000FinalHuman Genome Sciences Conference Call TranscriptHGSI11:00am ET...Good morning and welcome to the Human Genome Sciences conference call. Today's call is being recorded. At this time, I will turn the call over to H. Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. Please go ahead. ... TranscriptT1726893Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1678547ccbn/B1678547norm11/1/2007 1:13:00 PMHuman Genome Sciences54.0000EditedQ3 2007 Human Genome Sciences Earnings Conference Call SummaryHGSI11:00am ET...Co. believes both have great therapeutic potential and commercial potential to become blockbusters in marketplace. ... BriefB1678547Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1678547ccbn/T1678547norm11/1/2007 12:13:00 PMHuman Genome Sciences54.0000FinalQ3 2007 Human Genome Sciences Earnings Conference Call TranscriptHGSI11:00am ET...Good morning, and welcome to the Human Genome Sciences third quarter financial results conference call. Today's call is being recorded.At this time, I would like to turn the call over to Mr. H. Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences. Mr. Watkins, please go ahead. ... TranscriptT1678547Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/B1612326ccbn/B1612326norm8/1/2007 1:15:00 PMHuman Genome Sciences54.0000EditedQ2 2007 Human Genome Sciences Earnings Conference Call SummaryHGSI11:00am ET...Edging toward the finish line with Albuferon for the treatment of Hepatitis C and LymphoStat-B for the treatment of lupus. ... BriefB1612326Credit & Investment ResearchThomson Street Events